These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dangers of anti-Kell in pregnancy. Lancet; 1991 Jun; 337(8753):1319-20. PubMed ID: 1674303 [No Abstract] [Full Text] [Related]
4. Pregnancy outcome in mothers who develop Kell antibodies. Farr V; Gray E Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288 [TBL] [Abstract][Full Text] [Related]
5. Two additional examples of non-transfusion-stimulated anti-Kell. Clark A; Monaghan WP; Martin CA Am J Med Technol; 1981 Dec; 47(12):983-4. PubMed ID: 7332023 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940 [TBL] [Abstract][Full Text] [Related]
9. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Wenk RE; Goldstein P; Felix JK Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome in mothers who develop Kell antibodies. Boulton FE Scott Med J; 1989 Jun; 34(3):454. PubMed ID: 2501868 [No Abstract] [Full Text] [Related]
11. Anti-K (kell) antibodies in pregnancy. Gunston KD; Moller GH; Botha I S Afr Med J; 1991 Feb; 79(3):168-9. PubMed ID: 1994491 [No Abstract] [Full Text] [Related]
12. Febrile Neutropenia following Parvovirus B19 Infection and Cross Anti-Kell Reaction to E. Coli in Pregnancy. Brandão P; Freixo M; Soares E; Estevinho C; Carvalho ASP; Melo A Rev Bras Ginecol Obstet; 2018 Jun; 40(6):372-376. PubMed ID: 29925108 [TBL] [Abstract][Full Text] [Related]
13. Current clinical management of anti-Kell alloimmunization in pregnancy. Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801 [TBL] [Abstract][Full Text] [Related]
15. Alloimmunization to both Rh and Kell system antigens (anti-C and anti-K) in a young thalassemic patient. Arora S; Dhawan HK; Sachdev S; Patidar G; Sharma RR; Marwaha N; Trehan A; Marwaha RK Indian J Pathol Microbiol; 2010; 53(4):889-90. PubMed ID: 21045471 [No Abstract] [Full Text] [Related]
16. [Isoimmunization to Kell factor, during pregnancy]. Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245 [No Abstract] [Full Text] [Related]
17. Incidence and persistence of anti-Kell after transfusion of Kell-positive blood. Schabel A; König AL; Schiebel MR; Sugg U Beitr Infusionsther Transfusionsmed; 1994; 32():175-8. PubMed ID: 9422111 [TBL] [Abstract][Full Text] [Related]
18. Anti Kell allo-antibody in a thalassaemic. Thakral B; Saluja K; Sharma RR; Marwaha N; Marwaha RK Indian J Pathol Microbiol; 2006 Jan; 49(1):37-9. PubMed ID: 16625974 [TBL] [Abstract][Full Text] [Related]
19. Kell expression on myeloid progenitor cells. Wagner T; Lanzer G; Geissler K Leuk Lymphoma; 2002 Mar; 43(3):479-85. PubMed ID: 12002749 [TBL] [Abstract][Full Text] [Related]
20. [A successfully treated case of congenital hydrops by Kell-alloimmunization]. Görbe E; Hajdú J; Lipták M; Machay T; Molnár V; Czinyéri J; Papp Z Orv Hetil; 1992 Dec; 133(49):3151-2. PubMed ID: 1454359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]